DC Field | Value | Language |
dc.contributor.author | Pantea, V. | |
dc.contributor.author | Cebotarescu, V. | |
dc.contributor.author | Smesnoi, V. | |
dc.date.accessioned | 2020-03-30T22:15:03Z | |
dc.date.available | 2020-03-30T22:15:03Z | |
dc.date.issued | 2010 | |
dc.identifier.citation | PANTEA, V., CEBOTARESCU, V., SMESNOI, V. TThe treatment with cytomix of patients with chronic viral hepatitis B, C and mixed B and C. In: Curierul Medical. 2010, nr. 6(318), pp. 58-61. ISSN 1875-0666. | en_US |
dc.identifier.issn | 1875-0666 | |
dc.identifier.uri | http://moldmedjournal.md/wp-content/uploads/2016/09/28.pdf | |
dc.identifier.uri | http://repository.usmf.md/handle/20.500.12710/8344 | |
dc.description | Department of Contagious Diseases, Postgraduate Study Faculty, Nicolae Testemitanu State Medical and Pharmaceutical University, Clinical Hospital of Contagious Diseases “Toma Ciorba,” Chisinau, Republic of Moldova | en_US |
dc.description.abstract | The treatment with cytomix of 20 patients with chronic viral hepatitis B, C, and mixed B+C, for the duration of three months was favored.
The improvement of clinical symptoms in patients with HVBC, HVC, and HVBC+HVCC. The decrease and normalization of liver and spleen
sizes, and moderate decrease of cytolysis indices values (ALAT, ASAT). Seroconversion in the AgHBs and anti-Hbs system with the formation
of anti-HBs (protective antibodies) in one of nine patients with the diagnosis HVBC. The improvement of immune status indices, which was
more marked in patients with HVBC and HVBC+HVCC; there were no noted clinical, biochemical or immunological improvements in the
patients of the control group. | en_US |
dc.description.abstract | Лечение цитомиксом проводилось у 20 больных вирусными гепатитами В и С и микст гепатитами В+С в течении 3-х месяцев.
Лечение привело к исчезновению клинической симптоматики, нормализации размеров печени и селезенки и снижению активности
АЛАТ и АСАТ. Произошла сероконверсия в системе НBsAg и анти-HBs с образованием анти-HBs у одного больного из 9 с хроническим
вирусным гепатитом В. Улучшение иммунологического статуса было более выражено у больных с хроническим вирусным гепатитом
В и микст гепатитом В+С, чего не наблюдалось у пациентов контрольной группы. | |
dc.language.iso | en | en_US |
dc.publisher | Ministerul Sănătăţii al Republicii Moldova, Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu” | en_US |
dc.relation.ispartof | Curierul Medical | |
dc.subject | chronic | en_US |
dc.subject | viral | en_US |
dc.subject | hepatitis B | en_US |
dc.subject | C | en_US |
dc.subject | Cytomix | en_US |
dc.subject.mesh | Hepatitis B, Chronic--drug therapy | en_US |
dc.subject.mesh | Hepatitis С, Chronic--drug therapy | en_US |
dc.subject.mesh | Citomix--therapeutic use | en_US |
dc.title | The treatment with cytomix of patients with chronic viral hepatitis B, C and mixed B and C | en_US |
dc.title.alternative | Лечение цитомиксом больных хроническим вирусным гепатитом В и С и микст гепатитом В+С | en_US |
dc.type | Article | en_US |
Appears in Collections: | Curierul Medical, 2010, Vol. 318, Nr. 6
|